NAS
IDYA icon

Nykredit A/S’s IDEAYA Biosciences IDYA Stock Holding History

Nykredit A/S’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$76.2K Buy
+2,045
New +$62.6K ﹤0.01% 1403

Other funds holding IDYA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $27.6B AUM 23.56% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
GP
GSK plc London $602M AUM

Nykredit A/S's IDYA Position: Q2 2026 in Review

Nykredit A/S opened a new position in IDEAYA Biosciences (IDYA) in Q2 2026: 2,045 shares worth $76.2K. The stake represents ﹤0.01% of the portfolio and ranks #1403 among its holdings.

196 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • Nykredit A/S held 2,045 shares of IDEAYA Biosciences worth $76.2K as of Q2 2026.
  • IDEAYA Biosciences was a new Nykredit A/S position in Q2 2026.
  • IDEAYA Biosciences made up ﹤0.01% of Nykredit A/S's portfolio in Q2 2026, its #1403 holding.
  • 196 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on Nykredit A/S's 13F filing for Q2 2026, filed 13 Aug 2026.